Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-14 Sale |
2023-04-18 5:49 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $11.88 | $27,597 | 369,494 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 7:04 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $10.32 | $23,973 | 371,817 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-13 5:57 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
4,000 | $10.2 | $40,800 | 360,190 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 7:34 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $10.05 | $23,346 | 374,140 (Direct) |
View |
| 2022-12-14 Sale |
2022-12-16 7:36 pm |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
50,000 | $11.19 | $559,500 | 1,443,364 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 5:59 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,084 | $10.73 | $22,361 | 313,520 (Direct) |
View |
| 2022-11-22 Sale |
2022-11-23 6:57 pm |
Theravance Biopharma Inc. | TBPH | O'Connor Donal Director |
10,000 | $10.5 | $105,000 | 43,886 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 4:07 pm |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
65,000 | $11.02 | $716,242 | 384,714 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-02 Option Award |
2023-05-04 6:48 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | PAKIANATHAN DEEPIKA Director |
31,176 | $0 | 58,923 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:46 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | O'Connor Donal Director |
31,176 | $0 | 75,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:43 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | MITCHELL DEAN J Director |
31,176 | $0 | 92,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:41 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | MALKIEL BURTON G Director |
31,176 | $0 | 137,633 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:38 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | GRAY SUSANNAH Director |
31,176 | $0 | 42,995 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:36 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | BROSHY ERAN Director |
31,176 | $0 | 92,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:33 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | Smaldone Alsup Laurie Director |
31,176 | $0 | 75,838 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:41 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
330,000 | $0 | 1,735,944 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:38 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
80,000 | $0 | 277,717 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:35 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
75,000 | $0 | 304,958 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:32 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
75,000 | $0 | 376,463 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
75,000 | $0 | 364,190 (Direct) |
View |
| 2023-02-26 Option Award |
2023-02-28 8:17 pm |
N/A 2033-02-25 |
Theravance Biopharma Inc. | TBPH | GRAY SUSANNAH Director |
44,485 | $0 | 44,485 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
37,420 | $10.44 | 1,405,944 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:27 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
6,783 | $10.44 | 197,717 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:23 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
10,198 | $10.44 | 229,958 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:21 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
12,057 | $10.44 | 301,463 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:18 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
7,119 | $10.44 | 289,190 (Direct) |
View |
Ownership |
2023-02-22 5:05 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, Gen Counsel and Secretary |
0 | $0 | 240,156 (Direct) |
View |
Ownership |
2023-01-10 5:56 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & Chief Financial Officer |
0 | $0 | 204,500 (Direct) |
View |
| 2022-12-13 Gift |
2022-12-16 7:36 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
9,000 | $0 | 1,443,364 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:09 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $10.85 | 1,502,364 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:07 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,057 | $10.85 | 384,714 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:04 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
27,350 | $10.85 | 315,604 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:02 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
23,268 | $10.85 | 296,309 (Direct) |
View |
| 2022-11-16 Tax Withholding |
2022-11-17 7:53 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,800 | $11.2 | 342,954 (Direct) |
View |
Ownership |
2022-10-21 7:35 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Samaha Eli 10% Owner |
0 | $0 | 7,012,226 (Indirect) |
View |
Ownership |
2022-09-28 09:33 am |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Weiss Asset Management LP WEISS ANDREW M WAM GP LLC 10% Owner |
0 | $0 | 7,457,060 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
269,061,000 | $0 | 9,644,807 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
9,644,807 | $9.75 | 9,644,807 (Indirect) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 7:03 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $9.34 | 1,517,351 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 7:00 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,676 | $9.34 | 473,507 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 6:57 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
18,991 | $9.34 | 345,754 (Direct) |
View |